Novartis Pharma AG
Lichtstrasse 35
Basel
CH-4002
United States
Tel: 41-61-324-111
Fax: 41-61-324-8001
Website: http://www.novartis.com/
105 articles about Novartis Pharma AG
-
Emisphere Technologies, Inc., Novartis Pharma AG. Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT
7/23/2010
-
Emisphere Technologies, Inc. Announces Expanded Collaboration Agreement With Novartis Pharma AG and Cancellation of Convertible Promissory Note
6/4/2010
-
Titan Pharmaceuticals Provides Estimate of Upcoming Royalty Payment
4/22/2010
-
Emisphere Technologies, Inc. Partner Initiates Second Phase I Trial for Oral PTH Therapy for the Treatment of Postmenopausal Osteoporosis
4/15/2010
-
Novartis Pharma AG Reports Positive Results From Phase II LCZ696 Trial
3/17/2010
-
Emisphere Technologies, Inc. Announces Extension of Maturity Date for Novartis Pharma AG Convertible Promissory Note
11/30/2009
-
Idenix Pharmaceuticals, Inc. Says Novartis Pharma AG (JOBS) Not to License Hepatitis C Drug
10/30/2009
-
QLT Inc. Gets Rights to Sell Visudyne in US from Novartis Pharma AG (JOBS)
10/19/2009
-
Novartis Pharma AG (JOBS) Acquires Exclusive Rights From Vanda Pharmaceuticals, Inc. for Commercialization of Fanapt in the United States and Canada; Novartis to Pay $200 Million Upfront
10/13/2009
-
BTG plc Sells HySolv(TM) Technology to Major Pharmaceutical Company Novartis Pharma AG
8/28/2009
-
Novartis Pharma AG (JOBS) Obtains EU Positive Opinion For New Biologic Drug
7/29/2009
-
Medarex, Inc. to Receive Milestone Payment from Novartis Pharma AG for the Approval of Ilaris for the Treatment of Cryopyrin-Associated Periodic Syndrome
6/30/2009
-
Regeneron Pharmaceuticals, Inc. Converts Interleukin-1 Antibody Opt-In Rights to Royalty Agreement With Novartis Pharma AG
6/11/2009
-
Novartis Pharma AG Wants to Raise Stake in Indian Subsidiary
3/25/2009
-
Ipsen Announces The Signature Of A Co-Promotion Agreement With Novartis Pharma AG For Exforge(R) In France
1/28/2009
-
Aureus Pharma to Participate in a European Consortium for Drug Cardiac Toxicity
10/30/2008
-
Elixir Medical Licenses Myolimus(TM) From Novartis Pharma AG for Site-Specific Drug Delivery Applications
10/10/2008
-
Antibody Drug Cost-Effective For Allergic Asthma, University of Washington and Novartis Pharma AG Study
6/4/2008
-
Novartis Pharma AG Release: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
12/10/2007
-
Roche (Jobs), Ortho-Clinical Diagnostics, Novartis Pharma AG (Jobs) Deal on Hepatitis C Diagnostics
11/13/2007